Everlywell

Everlywell is offering Clairity Breast, an FDA-approved AI tool that calculates a five-year breast cancer risk score from a single mammogram for $249 out-of-pocket. The tool analyzes mammogram patterns imperceptible to the human eye and categorizes risk as average (<1.7%), intermediate (1.7-3%), or high (>3%), though it is a forecast and does not detect existing tumors.